Pharmaceuticals

Intravenous Immunoglobulin Market Outlook 2025–2029: Emerging Opportunities and Key Drivers

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the intravenous immunoglobulin market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Intravenous Immunoglobulin Market And What Value Is Projected For 2029?

The intravenous immunoglobulin market size has experienced robust expansion over recent years. This market is projected to expand from $14.66 billion in 2024 to $15.57 billion by 2025, driven by a compound annual growth rate (CAGR) of 6.2%. Historically, this expansion has been driven by several factors, including the treatment of primary immunodeficiency disorders, the management of various neurological conditions, an increasing geriatric population, improvements in plasma fractionation techniques, broader applications in neurology, the treatment of infectious diseases, and specific treatments for pediatric immunodeficiency.

The intravenous immunoglobulin market size is projected to experience substantial expansion over the upcoming years. It is anticipated to reach “$21.53 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.4%.” This growth during the forecast period can be attributed to factors such as an increasing incidence of autoimmune disorders, ongoing research in immunology, rising healthcare expenditure, a growing incidence of cancer, innovation in immunoglobulin products, and personalized medicine approaches. Major trends expected in the forecast period include advancements in primary immunodeficiency disorders (PIDD) treatment, rapid technological innovations, strategic collaborations and partnerships, improvements in manufacturing processes, expanding indications in neurology, increased use in hematology, and progress in immunotherapy.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8538&type=smp

What Factors Are Boosting The Intravenous Immunoglobulin Market?

The growing geriatric population is anticipated to propel the intravenous immunoglobulin market. This demographic refers to individuals above 65 years of age. As people age, their immune systems often function less effectively, resulting in a deficiency of antibodies. Consequently, they require immunoglobulins to provide them with necessary antibodies. This increased need for intravenous immunoglobulins is expanding market demand. For instance, in January 2024, according to the Population Reference Bureau, a Kenya-based Nonprofit organization, the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, a 47% increase. This age group’s share of the overall population is also projected to rise from 17% to 23% during the same period. As a result, the increasing geriatric population will drive the growth of the intravenous immunoglobulin market forward.

What Are The Core Segmentation Criteria In The Intravenous Immunoglobulin Market?

The intravenous immunoglobulin market covered in this report is segmented –

1) By Type: IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications

4) By End-User: Hospitals, Clinics, Home Care

Subsegments:

1) By Immunoglobulin G (IgG): Normal IgG, Specific IgG

2) By Immunoglobulin M (IgM): Normal IgM, Specific IgM

3) By Immunoglobulin A (IgA): Normal IgA, Specific IgA

4) By Immunoglobulin E (IgE): Normal IgE, Specific IgE

5) By Immunoglobulin D (IgD): Normal IgD, Specific IgD

Which Emerging Trends Are Reshaping The Intravenous Immunoglobulin Market Landscape?

Product innovation represents a significant trend gaining momentum in the intravenous immunoglobulin market. Major companies in this sector are concentrating on developing new offerings, such as liquid immune globulin formulations for treating immunodeficiency diseases, to strengthen their market presence. For instance, in December 2023, GC Pharma, a South Korea-based pharmaceutical company, introduced its US Food and Drug Administration (FDA) approved product, Alyglo. This sterile, ready-to-use liquid formulation contains 10% immunoglobulin G (IgG), supplying 100 mg/mL of protein, with at least 96% being human IgG derived from pooled human plasma. Its specific indication is for the management of primary humoral immunodeficiency (PI) in adults aged 17 years and older, covering conditions like congenital agammaglobulinemia, common variable immunodeficiency (CVID), Wiskott-Aldrich syndrome, and severe combined immunodeficiency (SCID).

Which Players Are Shaping The Competitive Landscape Of The Intravenous ImmunoglobulinXX Market?

Major companies operating in the intravenous immunoglobulin market are Bio Products Laboratory Limited, Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols S.A., Kedrion SpA, Shanghai RAAS Blood Products Co. Ltd., Octapharma AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., LFB Biotechnologies SAS, BDI Pharma Inc., Hualan Biological Engineering Inc., ADMA Biologics Inc., Bharat Serums and Vaccines Limited, Sanquin Plasma Products B.V., Prothya Biosolutions B.V., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Pfizer Inc., Kedrion Biopharma, Intas Pharmaceuticals, Octapharma Pharmazeutika Produktionsges.m.b.H., GC Pharma, Grifols Biologicals Inc., Kamada Ltd., LFB USA, Octapharma Plasma Inc., Panacea Biotec Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report

What Regional Trends Are Shaping Growth In The Intravenous Immunoglobulin Market?

North America was the largest region in the intravenous immunoglobulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous immunoglobulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=8538&type=smp

Browse Through More Reports Similar to the Global Intravenous Immunoglobulin Market 2025, By The Business Research Company

Immunoglobulins Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Immunosuppressant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunosuppressant-global-market-report

Immunofluorescence Assay Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795